- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/04 - 1,2,3-OxadiazolesHydrogenated 1,2,3-oxadiazoles
Patent holdings for IPC class C07D 271/04
Total number of patents in this class: 80
10-year publication summary
|
10
|
7
|
8
|
6
|
2
|
5
|
4
|
2
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1889 |
11 |
| Melior Pharmaceuticals II, LLC | 5 |
5 |
| Bayer Pharma AG | 1029 |
4 |
| Caliper Life Sciences, Inc. | 86 |
4 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11010 |
3 |
| C.n.c.c.s. Scarl Collezione Nazionale DEI Composti Chimici e Centro Screening | 20 |
3 |
| Incyte Holdings Corporation | 637 |
3 |
| Irbm S.p.A. | 26 |
3 |
| Bristol-myers Squibb Company | 4812 |
2 |
| BASF SE | 21113 |
2 |
| Syngenta Crop Protection AG | 6466 |
2 |
| Centre National de La Recherche Scientifique | 10865 |
2 |
| Blade Therapeutics, Inc. | 15 |
2 |
| C4X Discovery Limited | 25 |
2 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1007 |
2 |
| Universite de Strasbourg | 705 |
2 |
| F. Hoffmann-La Roche AG | 7835 |
1 |
| Hoffmann-La Roche Inc. | 3686 |
1 |
| The Regents of the University of California | 20534 |
1 |
| Massachusetts Institute of Technology | 10196 |
1 |
| Other owners | 24 |